NPPB
Basic information
Region (hg38): 1:11857464-11858945
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (22 variants)
- not_provided (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPPB gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002521.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 21 | 25 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 21 | 1 | 5 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| NPPB | protein_coding | protein_coding | ENST00000376468 | 3 | 1468 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.00000988 | 0.199 | 125712 | 0 | 32 | 125744 | 0.000127 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.152 | 88 | 84.1 | 1.05 | 0.00000523 | 840 | 
| Missense in Polyphen | 20 | 19.255 | 1.0387 | 218 | ||
| Synonymous | 0.101 | 34 | 34.8 | 0.978 | 0.00000184 | 302 | 
| Loss of Function | -0.414 | 7 | 5.91 | 1.18 | 3.50e-7 | 59 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000370 | 0.000368 | 
| Ashkenazi Jewish | 0.000963 | 0.000893 | 
| East Asian | 0.00 | 0.00 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.000130 | 0.000123 | 
| Middle Eastern | 0.00 | 0.00 | 
| South Asian | 0.00 | 0.00 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
- FUNCTION: Cardiac hormone which may function as a paracrine antifibrotic factor in the heart. Also plays a key role in cardiovascular homeostasis through natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion. Specifically binds and stimulates the cGMP production of the NPR1 receptor. Binds the clearance receptor NPR3. {ECO:0000269|PubMed:1672777}.;
- Pathway
- cGMP-PKG signaling pathway - Homo sapiens (human);MicroRNAs in cardiomyocyte hypertrophy;NO-cGMP-PKG mediated Neuroprotection;alk in cardiac myocytes (Consensus) 
Intolerance Scores
- loftool
- 0.700
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 80.58
Haploinsufficiency Scores
- pHI
- 0.0599
- hipred
- N
- hipred_score
- 0.182
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.557
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Nppb
- Phenotype
- muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of systemic arterial blood pressure;cGMP biosynthetic process;protein folding;cell surface receptor signaling pathway;receptor guanylyl cyclase signaling pathway;neuropeptide signaling pathway;body fluid secretion;regulation of blood pressure;regulation of signaling receptor activity;negative regulation of angiogenesis;cGMP-mediated signaling;negative regulation of cell growth;positive regulation of urine volume;positive regulation of renal sodium excretion;regulation of vascular permeability;regulation of blood vessel diameter
- Cellular component
- extracellular region;extracellular space;nucleus;cytoplasm;protein-containing complex
- Molecular function
- signaling receptor binding;hormone activity;protein binding;diuretic hormone activity;hormone receptor binding